Raleigh Capital Management’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-257
| Closed | -$23.3K | – | 1014 |
|
|
2024
Q1 | $23.3K | Hold |
257
| – | – | 0.01% | 403 |
|
|
2023
Q4 | $20.9K | Buy |
+257
| New | +$20.9K | 0.01% | 429 |
|
|
2023
Q3 | – | Sell |
-258
| Closed | -$20.3K | – | 943 |
|
|
2023
Q2 | $20.3K | Buy |
258
+2
| +0.8% | +$158 | 0.01% | 387 |
|
|
2023
Q1 | $19.9K | Hold |
256
| – | – | 0.01% | 374 |
|
|
2022
Q4 | $19.9K | Buy |
256
+2
| +0.8% | +$155 | 0.01% | 319 |
|
|
2022
Q3 | $17K | Buy |
254
+1
| +0.4% | +$67 | 0.01% | 303 |
|
|
2022
Q2 | $19K | Buy |
253
+1
| +0.4% | +$75 | 0.01% | 299 |
|
|
2022
Q1 | $20K | Buy |
+252
| New | +$20K | 0.01% | 295 |
|